We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WYETH REVISES PREGNANCY WARNINGS FOR EFFEXOR DRUGS
WYETH REVISES PREGNANCY WARNINGS FOR EFFEXOR DRUGS
June 29, 2004
Wyeth has announced it will change warning labeling on its antidepressant, Effexor and Effexor XR to reflect possible complications to neonates exposed to the product during the third trimester of pregnancy.